Modulation of Mx1-Cre Induction Pathways
Corresponding Organization :
Other organizations : California Institute for Regenerative Medicine, Albert Einstein College of Medicine, Memorial Sloan Kettering Cancer Center
Variable analysis
- Poly I:C (Invivogen) administered intraperitoneally (i.p.) every other day at 5 mg/kg for three doses for Mx1-Cre induction
- NAC (Sigma #A7250) administered at 50 mg/kg in PBS i.p. daily and supplemented at 1 mg/ml via drinking water which was refreshed twice a week
- CFZ (CFZ/PR-171, Selleckchem) injected intravenously at 2 mg/kg on days 1 and 2 of each week
- Rapamycin (sirolimus, Selleckchem) administered at 4 mg/kg i.p. daily and supplemented at 15 ng/ml in drinking water when specified
- RTKi PKC412 (Midostaurin, Selleck Chemicals #S8064) injected i.p. daily at 3 mg/kg
- LiCl (1 mEq/kg, Fisher #L121) injected i.p. daily
- Verapamil (25 mg/kg, Sigma #V4629) injected i.p. daily
- Not explicitly mentioned
- Not explicitly mentioned
- Positive control: Not specified
- Negative control: Not specified
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!